DAVID SMITH: Open Payments
NPI 1114902178 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$96,235 in 83 payments from 3 companies in 2025. Trend: 2023 $130,031 · 2024 $113,841 · 2025 $96,235
Speaker / faculty: $83,035Consulting: $6,888Travel & lodging: $4,479Food & beverage: $1,834
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 31 | $45,394 |
| Neurocrine BioSciences, Inc. | 27 | $34,072 |
| Janssen Pharmaceuticals, Inc | 25 | $16,769 |
Products named: REXULTI, INGREZZA, SPRAVATO, ABILIFY MAINTENA, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
